| 血清sCD105及ADAM12应用于子痫前期筛查的研究进展 |
| |
| 引用本文： | 杜习羽. 血清sCD105及ADAM12应用于子痫前期筛查的研究进展[J]. 海南医学, 2011, 22(7): 128-129 |
| |
| 作者姓名： | 杜习羽 |
| |
| 作者单位： | 南方医科大学附属深圳市妇幼保健院,广东,深圳,518028 |
| |
| 摘 要： | 子痫前期是妊娠期特有的疾病,是孕产妇及围生儿死亡的重要原因之一.针对其发病原因,多年来国内外许多研究进行了各方面的探索,提出多种学说,但具体机制仍未明确.可溶性CD105(sCD105)及分泌性/可溶性解整合素-金属蛋白酶12(ADAM12)可能与子痫前期的发病机制相关,本文就这两者的研究进展作一综述.
|
| 关 键 词： | sCD105 ADAM12 子痫前期 |
Research advances of sCD105 and ADAM12 in preeclampsia |
| |
| DU Xi-yu. Research advances of sCD105 and ADAM12 in preeclampsia[J]. Hainan Medical Journal, 2011, 22(7): 128-129 |
| |
| Authors: | DU Xi-yu |
| |
| Affiliation: | .Shenzhen Maternity and Children Healthcare Hospital,Shenzhen 518028,Guangdong CHINA |
| |
| Abstract: | Preeclampsia is a unique syndrome during pregnancy,and it is one of the important causes of maternal and perinatal death.Many domestic and foreign researches have been focusing on the pathogenesis of preeclampsia,and some theories have been proposed.However,its mechanism has not yet been clarified.It has been demonstrated by recent studies that a new anti-angiogenic protein,sCD105 and ADAM12s may be related to the pathogenesis of preeclampsia.This paper briefly introduces the research advances in relationship between sCD105 and ADAM12s to preeclampsia. |
| |
| Keywords: | sCD105 ADAM12 |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
|
